The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ArticleNo Access

Corrections

Published Online:https://doi.org/10.1176/ajp.134.4.463-b

There were two errors in the Conclusions of "γ-Aminobutyric Acid (Gaba) and the Dopamine Hypothesis of Schizophrenia" by Daniel P. van Kammen (Feburary 1977 issue, p. 142). In the first paragraph of that section, the third sentence should have read as follows: According to a personal communication from Snyder and Wyatt in 1976, the activity of Gaba receptors in brains of deceased schizophrenic patients is not different from the activity in brains of deceased normal control subjects. In the third paragraph, the second sentence should have read as follows: Muscimol, a relatively specific Gaba receptor agonist, was developed in 1968 (40).

The staff regrets these errors.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.